Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey

dc.authorid0000-0001-7628-700X
dc.contributor.authorErol, Mustafa Kemal
dc.contributor.authorKayıkçıoğlu, Meral
dc.contributor.authorKılıçkap, Mustafa
dc.contributor.authorArın, Can Baba
dc.contributor.authorKurt, İbrahim Halil
dc.contributor.authorAktaş, İbrahim
dc.contributor.authorGüneş, Yılmaz
dc.contributor.authorAsoğlu, Ramazan
dc.date.accessioned2021-06-07T10:57:49Z
dc.date.available2021-06-07T10:57:49Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.description*Asoğlu, Ramazan ( Aksaray, Yazar )
dc.description.abstractObjective: The TURKMI registry is designed to provide insight into the characteristics, management from symptom onset to hospital discharge, and outcome of patients with acute myocardial infarction (MI) in Turkey. We report the baseline and clinical characteristics of the TURKMI population. Methods: The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of percutaneous coronary intervention selected from each EuroStat NUTS region in Turkey according to population sampling weight, prioritized by the number of hospitals in each region. All consecutive patients with acute MI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018 and November 16, 2018. Results: A total of 1930 consecutive patients (mean age, 62.0±13.2 years; 26.1% female) with a diagnosis of acute MI were prospectively enrolled. More than half of the patients were diagnosed with non-ST elevation MI (61.9%), and 38.1% were diagnosed with ST elevation MI. Coronary angiography was performed in 93.7% and, percutaneous coronary intervention was performed in 73.2% of the study population. Fibrinolytic therapy was administered to 13 patients (0.018%). Aspirin was prescribed in 99.3% of the patients, and 94% were on dual antiplatelet therapy at the time of discharge. Beta blockers were prescribed in 85.0%, anti-lipid drugs in 96.3%, angiotensin converting enzyme inhibitors in 58.4%, and angiotensin receptor blockers in 7.9%. Comparison with European countries revealed that TURKMI patients experienced MI at younger ages compared with patients in France, Switzerland, and the United Kingdom. The most prevalent risk factors in the TURKMI population were hypercholesterolemia (60.2%), hypertension (49.5%), smoking (48.8%), and diabetes (37.9%). Conclusion: The nation-wide TURKMI registry revealed that hypercholesterolemia, hypertension, and smoking were the most prevalent risk factors. TURKMI patients were younger compared with patients in European Countries. The TURKMI registry also confirmed that current treatment guidelines are largely adopted into clinical cardiology practice in Turkey in terms of antiplatelet, anti-ischemic, and anti-lipid therapy.
dc.identifier.doi10.14744/AnatolJCardiol.2020.69696
dc.identifier.endpage53en_US
dc.identifier.issn2149-2263
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage43en_US
dc.identifier.urihttps:/dx.doi.org/10.14744/AnatolJCardiol.2020.69696
dc.identifier.urihttps://hdl.handle.net/20.500.12451/8077
dc.identifier.volume24en_US
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTurkish Society of Cardiology
dc.relation.ispartofAnatolian Journal of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcute Myocardial Infarction
dc.subjectCoronary Artery Disease
dc.subjectRegistry
dc.subjectTurkey
dc.titleBaseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
erol-mustafa kemal-2020.pdf
Boyut:
312.95 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: